Analysis of Human Genome Sciences Inc. : Market Research Report

Analysis of Human Genome Sciences Inc.

Published: May. 1, 2008 - 75 Pages

A. Executive Summary
B. Looking at the Industry: B.1 Industry Definition; B.2 Brief Profile of the Industry; B.3 Impacts on the Industry; B.4 Challenges Facing the Industry; B.5 Future Perspective
C. Industry PEST Framework Analysis: C.1 Political Aspects; C.2 Economic Aspects; C.3 Social Aspects; C.4 Technological Aspects
D. Looking at the Company: D.1 Company Profile; D.2 History of the Company; D.3 Ownership Pattern in the Company; D.4 Corporate Hierarchy; D.5 Organizational Divisions; D.6 Profiling the Key Executives; D.7 Products & Services; D.8 Recently in the News
E. Looking at Business: E.1 Business Segments; E.2 Geographical Segments; E.3 Company Subsidiaries
F. SWOT Framework Analysis: F.1 Strengths to Build Upon; F.2 Weaknesses to Overcome; F.3 Opportunities to Exploit; F.4 Threats to Overcome
G. Profiling the Competition: G.1 Amgen Inc.; G.2 Glaxosmithkline plc
H. Financial Analysis of the Company: H.1 Current Financials; H.2 Balance Sheet; H.3 Profit & Loss Statement; H.4 Ratio Analysis
I. Future Perspective
J. Appendix
K. Glossary of Terms

Abstract

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these products are progressing toward commercialization. HGS also has a portfolio of drugs in earlier stages of development, led by its TRAIL receptor antibodies in mid-stage development for cancer, and substantial financial rights to three drugs in the GlaxoSmithKline (GSK) clinical pipeline.

Aruvian Research presents Analysis of Human Genome Sciences Inc. A complete and comprehensive analysis of Human Genome Sciences, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself.

Company analysis from Aruvian includes a history of Human Genome Sciences, a business segment analysis of the segments Human Genome Sciences operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors.

A financial analysis of Human Genome Sciences is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of Human Genome Sciences completes this in-depth company analysis.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Analysis of Human Genome Sciences Inc.

Table of Contents

Abstract